Literature DB >> 25278804

Peripheral ulcerative keratitis: Our challenging experience.

Bandar Al-Qahtani1, Salman Asghar2, Hassan Mohammad Al-Taweel3, Imran Jalaluddin4.   

Abstract

A 52 year old male presented with peripheral ulcerative keratitis in the right eye. Patient's history included retinitis pigmentosa, pseudophakia (right eye), cataract (left eye), bilateral partial deafness, ischemic heart disease, hypertension, type 1 diabetes mellitus, depression, hyperparathyroidism, hypertriglycemia and renal failure. The patient was on weekly hemodialysis. The peripheral corneal ulceration remained stable until he developed sudden and rapid thinning after eight months of regular follow up and management. Laboratory investigations including immunological studies were negative and we had to rely on treatment based on clinical signs, including the visual acuity, size, depth and staining of the ulcer and perilimbal, episcleral, scleral, corneal and anterior chamber reactions. The patient was treated with medical and conservative approaches and the eye was protected with a plastic shield to avoid injury. Despite our efforts, the patient perforated his eye due to a trivial trauma during sleep. He was managed successfully with cyanoacrylate glue and a bandage contact lens. The anterior chamber reformed after the perforation was sealed and the patient is on a regular follow up with a multidisciplinary approach.

Entities:  

Keywords:  Amniotic membrane transplantation; Connective tissue diseases; Immune complex deposition; Impending perforation; Peripheral corneal thinning; Peripheral ulcerative keratitis; Topical cyclosporine eye drops

Year:  2013        PMID: 25278804      PMCID: PMC4181453          DOI: 10.1016/j.sjopt.2013.12.006

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  9 in total

1.  Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential.

Authors:  K Suomalainen; T Sorsa; L M Golub; N Ramamurthy; H M Lee; V J Uitto; H Saari; Y T Konttinen
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristics.

Authors:  A R Clewes; J K Dawson; S Kaye; R C Bucknall
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

Review 3.  Peripheral ulcerative keratitis and collagen vascular disease.

Authors:  Y Shiuey; C S Foster
Journal:  Int Ophthalmol Clin       Date:  1998

4.  Immunosuppressive therapy for external ocular inflammatory disease.

Authors:  C S Foster
Journal:  Ophthalmology       Date:  1980-02       Impact factor: 12.079

5.  Tectonic keratoplasty for peripheral ulcerative keratitis.

Authors:  M B Raizman; M Sainz de la Maza; C S Foster
Journal:  Cornea       Date:  1991-07       Impact factor: 2.651

6.  Morphologic characterization of organized extracellular matrix deposition by ascorbic acid-stimulated human corneal fibroblasts.

Authors:  Xiaoqing Guo; Audrey E K Hutcheon; Suzanna A Melotti; James D Zieske; Vickery Trinkaus-Randall; Jeffrey W Ruberti
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

7.  Cyclosporine for ocular inflammatory diseases.

Authors:  R Oktay Kaçmaz; John H Kempen; Craig Newcomb; Ebenezer Daniel; Sapna Gangaputra; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; Grace A Levy-Clarke; C Stephen Foster
Journal:  Ophthalmology       Date:  2010-01-19       Impact factor: 12.079

8.  Update on peripheral ulcerative keratitis.

Authors:  Ayse Yagci
Journal:  Clin Ophthalmol       Date:  2012-05-14

9.  Amniotic membrane transplantation in surgically induced necrotizing scleritis with peripheral ulcerative keratitis.

Authors:  Shreya Thatte; Lalita Gupta
Journal:  Middle East Afr J Ophthalmol       Date:  2012-10
  9 in total
  1 in total

Review 1.  Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment.

Authors:  Yan Cao; Wensong Zhang; Jie Wu; Hong Zhang; Hongyan Zhou
Journal:  J Ophthalmol       Date:  2017-07-13       Impact factor: 1.909

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.